Ian Hayes

Ian commenced his articles at Cliffe Dekker & Todd in 1991 and remained with the firm until September 2012. Ian moved onto ENSafrica as Director, joint head and subsequently joint business unit leader of the corporate commercial department. Ian re-joined CDH in 2021.

• Advised Adcock Ingram on the disposal of 53.47% of the entire issued share capital of Ayrton Drug Manufacturing.
• Advised the Bakgatla Ba Kgafela Tribe on its disposal of shares in Bakgatla Pallinghurst JV.
• Advised the Bakgatla Ba Kgafela Tribe on its disposal of shares in Itereleng Bakgatla Minerals Resources to Pilanesberg Platinum Mines.
• Advised Business Connexion on the acquisition by Telkom of the entire issued share capital of Business
• Connexion by way of a scheme of arrangement in terms of section 114 of the Companies Act.

• M&A
• Private equity

• Financial services
• Healthcare
• Industrials
• Pharma and life sciences
• Tech and telecoms

• South Africa 

• BA, University of the Witwatersrand
• LLB, University of the Witwatersrand
• Leadership in Professional Service Firms, Harvard Business School